VA

Healthcare · Pharmaceuticals

Vaishali Pharma Ltd (VAISHALI)

₹6.84

Mkt cap
₹97 Cr
P/E ratio
18.90
P/B
1.13
Div yield
0.00%
ROE
6.02%
ROCE
8.93%
EPS (TTM)
₹0.36
Book value
₹6
52W range
5–10
Sector
Healthcare

Price history

Previous close

Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients [1]

NSE VAISHALI
Health check
Cautious
ValuationCheap
ProfitabilityWeak
GrowthLow
TechnicalsNeutral
52-week range
−30.70% from high
₹7
₹5+44.00% from low₹10
Current
₹6.84
Prev close
₹7.23
Day
−5.39%
Price performance
1D
−5.39%
1W
−3.25%
1M
−5.39%
3M
−13.96%
6M
−2.15%
1Y
−28.97%
YTD
−21.74%

Financials

Revenue, profit & margin
P/E ratio
18.9×
VAISHALI is 43% below the sector median of 33.4×
VAISHALI18.9×
Sector median33.4×
 Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Trend
Sales12.5727.9032.4018.0820.7927.9132.2523.7533.4524.6526.9322.8930.17
YoY Sales growth-4.48%+38.88%+23.48%+34.72%+65.39%+0.04%-0.46%+31.36%+60.89%-11.68%-16.50%-3.62%-9.81%
Expenses9.9224.9539.1915.7318.3726.5538.2922.3832.0623.0927.1321.4028.11
Operating Profit2.652.95-6.792.352.421.36-6.041.371.391.56-0.201.492.06
OPM %21.08%10.57%-20.96%13.00%11.64%4.87%-18.73%5.77%4.16%6.33%-0.74%6.51%6.83%
Other Income0.300.470.910.420.711.071.000.840.840.891.260.580.95
Interest0.470.430.400.380.380.380.440.330.400.510.720.200.39
Depreciation0.120.120.140.120.120.120.120.140.170.130.160.140.14
Profit before tax2.362.87-6.422.272.631.93-5.601.741.661.810.181.732.48
Tax %27.97%26.13%-26.95%25.11%25.10%24.87%-23.39%26.44%28.31%28.18%-50.00%13.87%16.94%
Net Profit1.702.11-4.681.701.971.44-4.291.281.181.300.271.492.07
EPS in Rs0.160.20-0.440.160.180.13-0.400.120.090.100.020.110.15
Raw PDF

Earnings

Results dates & reactions
No upcoming results date on calendar.

Fresh quarters land in the Financials table above, tagged NSE until screener catches up.

Avg earnings-day move −2.00% · closed higher next day 0 of last 1
 Q1FY27
Broadcast14 Aug '26◦
Earnings day−2.00%
+1 day−1.18%
+5 days−4.58%
+15 days−1.65%
+30 days−1.41%
FilingPDF

Corporate actions

Last 6 months

No recent corporate actions

Dividends, splits, and bonuses in the last six months show up here.

Shareholding

as of Sep 2026
31.61%Promoter
Promoters31.61%
Public68.39%
Ownership trend

Peers

8 companies
Valuation vs quality
P/E × ROCE · bubble = market cap
NameCMPP/EMkt CapDiv YldNP QtrQtr Profit VarSales QtrQtr Sales VarROCE
Sun Pharma.Inds.₹1,870.0036.464,48,6760.86%1,995−10.53%16,199+11.88%20.53%
Divi's Lab.₹11,150.0086.622,95,9970.27%1,127+63.57%3,676+35.40%21.97%
Torrent Pharma.₹4,668.8081.801,77,5860.81%534−10.03%4,979+50.79%15.19%
Laurus Labs₹2,338.0094.281,26,3250.09%436+126.43%2,206+33.44%17.76%
Zydus Lifesci.₹1,204.2026.511,20,1190.08%928−27.96%7,910+29.17%21.14%
Dr Reddy's Labs₹1,388.0041.411,15,9360.58%913−31.35%8,698−1.48%13.04%
Cipla₹1,388.0036.111,12,1350.94%852−35.05%7,404−2.44%15.49%
Vaishali Pharma₹7.1718.87970.00%2+75.42%30−9.81%8.93%
Median: 160 Co.₹445.7333.352,0160.08%13+33.73%179+21.23%14.94%

Filings